A breakthrough cancer vaccine is being tested on patients suffering from melanoma and could prevent thousands of deaths a year.
Results will be revealed later this year from the second of three trials by manufacturers Moderna and Merck.
It is a vaccine which is personalised and given for the individual condition of patients that have skin cancer.
